Heart failure in patients with acute myeloid leukemia (AML) treated with anthracycline agents during remission induction therapy: a systematic review and meta-analysis

Related articles

1. The Outcome of Older Patients with Acute Myeloid Leukemia Based on the SEER Database in the Era of Targeted Therapy

   This article has 5 authors:

   1. Xiaojing Lin
   2. Zhenyi Zhao
   3. Jing Wang
   4. Xun Ni
   5. Xingli Zou

2. Impact of Diagnosis-to-Treatment Interval on the Outcome of Patients with Acute Myeloid Leukemia

   This article has 14 authors:

   1. Samah Nassereddine
   2. Yuan Feng
   3. Jordan Selep
   4. Firas El Chaer
   5. Leah Wells
   6. Ramey Elsarrag
   7. Kimberly Doucette
   8. Vanya Aggarwal
   9. lacey Williams
   10. Imad Tabbara
   11. Shanshan Liu
   12. Guoquing Diao
   13. Mary-Elizabeth M. Percival
   14. Catherine Lai

3. Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry

   This article has 30 authors:

   1. Maël Heiblig
   2. Zofia Gross
   3. Amine Belhabri
   4. Urbain Tauveron-Jalenques
   5. Emmanuelle Tavernier
   6. Gaspar Aspa Requena
   7. Martin Carre
   8. Adrien Contejean
   9. Nadine Boullanger
   10. Clémence Santana
   11. Clément Rocher
   12. Sylvain Lamure
   13. Gian Matteo Pica
   14. Mauricette Michallet
   15. Jerome Cornillon
   16. Mathieu Meunier
   17. Natacha Mauz
   18. Samy Chraibi
   19. Ugo Thevenet
   20. Arthur Dony
   21. Grégoire Le Meur
   22. Lucie Coster
   23. Sylvie Tondeur
   24. Emmanuel Beillard
   25. Serge Carillo
   26. Delphine Manzoni
   27. Pascale Flandrin-Gresta
   28. Thomas Tassin
   29. Sarah Huet
   30. Adriana Plesa